GNOM.L vs. WHEA.L
GNOM.L (Global X Genomics & Biotechnology UCITS ETF) and WHEA.L (State Street SPDR MSCI World Health Care UCITS ETF) are both Health & Biotech Equities funds - GNOM.L tracks the Global X Genomics & Biotechnology UCITS ETF while WHEA.L tracks the State Street SPDR MSCI World Health Care UCITS ETF. Both are passively managed. Over the past 3 years, GNOM.L returned 4.58%/yr vs 7.00%/yr for WHEA.L. A 0.56 correlation means they provide meaningful diversification when combined. GNOM.L charges 0.50%/yr vs 0.30%/yr for WHEA.L.
Performance
GNOM.L vs. WHEA.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GNOM.L achieves a 22.10% return, which is significantly higher than WHEA.L's 1.40% return.
GNOM.L
- 1D
- -0.17%
- 1M
- 11.69%
- 6M
- 15.71%
- YTD
- 22.10%
- 1Y
- 62.79%
- 3Y*
- 4.58%
- 5Y*
- —
- 10Y*
- —
WHEA.L
- 1D
- 0.44%
- 1M
- 3.82%
- 6M
- -0.33%
- YTD
- 1.40%
- 1Y
- 17.80%
- 3Y*
- 7.00%
- 5Y*
- 4.42%
- 10Y*
- 8.14%
GNOM.L vs. WHEA.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GNOM.L Global X Genomics & Biotechnology UCITS ETF | 22.10% | 19.30% | -17.99% | -5.77% | -37.21% | -8.59% |
WHEA.L State Street SPDR MSCI World Health Care UCITS ETF | 1.40% | 15.24% | 1.05% | 3.54% | -5.55% | 3.21% |
Correlation
The correlation between GNOM.L and WHEA.L is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.55 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.54 |
Correlation (All Time) Calculated using the full available price history since Nov 2, 2021 | 0.56 |
The correlation between GNOM.L and WHEA.L has been stable across timeframes, ranging from 0.54 to 0.56 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GNOM.L vs. WHEA.L — Risk / Return Rank
GNOM.L
WHEA.L
GNOM.L vs. WHEA.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GNOM.L) and State Street SPDR MSCI World Health Care UCITS ETF (WHEA.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GNOM.L | WHEA.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.00 | ||
| Sortino ratioReturn per unit of downside risk | +1.19 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.20 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 3.35 | 1.63 | +1.72 |
| Martin ratioReturn relative to average drawdown | 9.16 | 3.96 | +5.20 |
Loading charts...
Drawdowns
GNOM.L vs. WHEA.L - Drawdown Comparison
The maximum GNOM.L drawdown since its inception was -69.32%, which is greater than WHEA.L's maximum drawdown of -26.20%. Use the drawdown chart below to compare losses from any high point for GNOM.L and WHEA.L.
Loading charts...
Drawdown Indicators
| GNOM.L | WHEA.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.32% | -26.20% | -43.12% |
Max Drawdown (1Y)Largest decline over 1 year | -18.91% | -10.35% | -8.56% |
Max Drawdown (3Y)Largest decline over 3 years | -44.77% | -19.16% | -25.61% |
Max Drawdown (5Y)Largest decline over 5 years | — | -19.16% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.20% | — |
Current DrawdownCurrent decline from peak | -37.11% | -3.30% | -33.81% |
Average DrawdownAverage peak-to-trough decline | -47.16% | -4.76% | -42.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.92% | 4.27% | +2.65% |
Volatility
GNOM.L vs. WHEA.L - Volatility Comparison
Global X Genomics & Biotechnology UCITS ETF (GNOM.L) has a higher volatility of 8.41% compared to State Street SPDR MSCI World Health Care UCITS ETF (WHEA.L) at 5.90%. This indicates that GNOM.L's price experiences larger fluctuations and is considered to be riskier than WHEA.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GNOM.L | WHEA.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.41% | 5.90% | +2.51% |
Volatility (6M)Calculated over the trailing 6-month period | 22.18% | 11.52% | +10.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.87% | 15.11% | +14.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.11% | 14.27% | +18.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.11% | 14.73% | +18.38% |
GNOM.L vs. WHEA.L - Expense Ratio Comparison
GNOM.L has a 0.50% expense ratio, which is higher than WHEA.L's 0.30% expense ratio.
Dividends
GNOM.L vs. WHEA.L - Dividend Comparison
Neither GNOM.L nor WHEA.L has paid dividends to shareholders.
Frequently Asked Questions
GNOM.L and WHEA.L have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, WHEA.L is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.
WHEA.L is cheaper with a 0.30% expense ratio, compared with 0.50% for GNOM.L.
GNOM.L tracks Global X Genomics & Biotechnology UCITS ETF, while WHEA.L tracks State Street SPDR MSCI World Health Care UCITS ETF. They also come from different issuers: Global X and State Street. Their fees differ too: 0.50% for GNOM.L and 0.30% for WHEA.L.
Find the right allocation for GNOM.L and WHEA.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer